Routine Evaluation of Prostate Size Not As Effective in Cancer Screening

New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer. However the study suggests that if a man's PSA level is rising quickly, a prostate biopsy is reasonable to determine if he has prostate cancer.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews